pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$IXHLIncannex Healthcare Inc.

$IXHL
Norwest Nsw, AUupdated 13d ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
15
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(15)

view full pipeline →
pipeline depth15 products
Preclinical: 13Phase 1: 1Phase 3: 1
13Preclinical1Phase 11Phase 3
Phase 3
(acetazolamide + dronabinol)
Obstructive Sleep Apnea
Phase 1
Medchew Dronabinol
Chemotherapy Induced Nausea and Vomiting
Preclinical
(cannabidiol + dronabinol)
Restless Legs Syndrome
Preclinical
(cannabidiol + isoflurane)
Traumatic Brain Injury
Preclinical
(cannabidiol + nicotine)
Smoking Cessation
Preclinical
APIRx-1505
Crohn's Disease (Regional Enteritis)
Preclinical
APIRx-1701
Glaucoma
Preclinical
APIRx-1702
Keratoconjunctivitis Sicca (Dry Eye)
Preclinical
CanChew RX
Inflammatory Bowel Disease
Preclinical
CannQuit-O
Opium (Opioid) Addiction
Preclinical
Chewell
Substance (Drug) Abuse
Preclinical
Medchew-1502
Parkinson's Disease

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSAcompletedn=121
  • phase2Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritisterminatedn=20
  • phase1Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugscompletedn=125
🐶 Hiring Signal
No open roles indexed yet — view Incannex Healthcare Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$IXHL
SEC CIK
0001873875
country
AU
source
sec_tickers
top tags
Ophthalmology2IBD (Crohn's + UC)1Pulmonology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 10m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?